ARTICLE | Company News
Seattle Genetics, Roche deal
March 8, 2010 8:00 AM UTC
Seattle Genetics received an undisclosed milestone payment from Roche's Genentech Inc. unit under a 2002 deal in which Genentech has rights to use Seattle Genetics' antibody-drug conjugate (ADC) tech...